Matsuo K, Nakamoto M, Yasunaga C, Goya T, Sugimachi K
Kidney Center, Saiseikai Yahata Hospital, Kitakyushu, Japan.
Kidney Int. 1997 Sep;52(3):832-8. doi: 10.1038/ki.1997.401.
Dialysis-related amyloidosis (DRA) predominantly occurs in the osteoarticular structures. However, according to studies in the increasing number of long-term hemodialysis patients, DRA has also been systemically found to appear in the other tissues and organs as well. In this study, we investigated lingual amyloidosis in relation to systemic DRA. A total of 472 patients were studied who were on regular hemodialysis for more than 10 years, including 103 patients for more than 20 years. Eight of these patients (7 males and 1 female, mean age 59 +/- 8 years, range 46 to 68 years) developed lingual amyloidosis, seemingly as a result of beta2-microglobulin (beta2m) deposits. All patients demonstrating lingual amyloidosis had been treated with regular hemodialysis for more than 20 years (mean HD duration 23.6 +/- 1.4 years), and its morbidity was 7.8% in the 103 patients and 20% (6 patients) in the 30 patients treated for more than 23 years with hemodialysis. Hemodialysis (HD) duration with bioincompatible unsubstituted cellulose membranes in the 8 patients was longer than that in the control group without lingual amyloidosis (P < 0.05). Lingual amyloid nodules were whitish-yellow in color and varied in size, at least over 1 mm in diameter. Their consistency was firmer than the intact tongue. The location of the amyloid nodules could be classified into two types: (1) diffuse type (diffusely distributed over the tongue), and (2) lateral type (localized only in the lateral side of the tongue). Five of the eight patients with lingual amyloidosis complained of functional disturbances in the tongue, such as abnormal taste, or difficulty in mobility and articulation. No macroglossia was observed in any of these cases. It was thus concluded that DRA of the tongue is a very rare complication, occurring in the late stage of long-term hemodialysis patients, that disturbs their quality of life.
透析相关性淀粉样变(DRA)主要发生于骨关节结构。然而,根据对越来越多长期血液透析患者的研究发现,DRA也被系统性地发现出现在其他组织和器官中。在本研究中,我们调查了与系统性DRA相关的舌淀粉样变。共研究了472例接受规律血液透析超过10年的患者,其中103例透析时间超过20年。这些患者中有8例(7例男性,1例女性,平均年龄59±8岁,范围46至68岁)发生舌淀粉样变,似乎是β2微球蛋白(β2m)沉积的结果。所有表现出舌淀粉样变的患者均接受规律血液透析超过20年(平均透析时间23.6±1.4年),在103例患者中其发病率为7.8%,在30例接受血液透析超过23年的患者中发病率为20%(6例)。8例患者中使用生物不相容未取代纤维素膜进行血液透析(HD)的时间长于无舌淀粉样变的对照组(P<0.05)。舌淀粉样结节呈淡黄白色,大小不一,直径至少超过1mm。其质地比正常舌组织更硬。淀粉样结节的位置可分为两种类型:(1)弥漫型(在舌上弥漫分布),和(2)外侧型(仅局限于舌的外侧)。8例舌淀粉样变患者中有5例主诉舌部功能障碍,如味觉异常、活动和发音困难。所有这些病例均未观察到巨舌症。因此得出结论,舌部DRA是一种非常罕见的并发症,发生于长期血液透析患者的晚期,会干扰他们的生活质量。